Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rangering i aksjer #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aksjekurs
$0.00023723
Sist synkronisert: 2024-08-26
Markedsverdi
$1.41K
Endring (1 dag)
111.67%
Endring (1 år)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Kategori

Antall utestående aksjer for Pharnext S.A. (ALPHA)
Antall utestående aksjer per December 2023: 736.02K
Ifølge Pharnext S.A. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 736.02K. Ved slutten av December 2022 hadde selskapet 736.02K utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Pharnext S.A. (ALPHA) fra 2013 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 736.02K 0.00%
2023 736.02K 0.00%
2022 736.02K 0.00%
2021 736.02K 0.00%
2020 736.02K 0.00%
2019 736.02K 0.00%
2018 736.02K 0.00%
2017 736.02K 0.00%
2016 736.02K 0.00%
2015 736.02K 0.00%
2014 736.02K 0.00%
2013 736.02K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M 34,396.16%
US
62.19M 8,348.83%
NL
- -
CH
0.00 -100.00%
BE
- -
KR